RxSight

About:

RxSight is a medical device company that offers an intraocular lens and cataract surgery solutions.

Website: http://rxsight.com

Twitter/X: RxSight

Top Investors: RA Capital Management, Longitude Capital, Balance Point Capital Partners, Biomedical Advanced Research and Development Authority (BARDA), Oxford Finance LLC

Description:

RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens.

Total Funding Amount:

$351M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Aliso Viejo, California, United States

Founded Date:

1997-01-01

Contact Email:

anammar(AT)rxsight.com

Founders:

Robert Grubbs

Number of Employees:

101-250

Last Funding Date:

2024-05-08

IPO Status:

Public

© 2025 bioDAO.ai